Davis's Drug Guide
idecabtagene vicleucel
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
eye-da-kab-ta-jeen vik-loo-sel
Trade Name(s)
- Abecma
Ther. Class.
Pharm. Class.
CAR-T cell immunotherapies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Idecabtagene Vicleucel." Davis's Drug Guide Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580199/all/idecabtagene_vicleucel.
Vallerand AHA, Sanoski CAC. Idecabtagene vicleucel. Davis's Drug Guide Davis's Drug Guide. F.A. Davis Company; 2026. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580199/all/idecabtagene_vicleucel. Accessed October 12, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Idecabtagene vicleucel. In Davis's Drug Guide Davis's Drug Guide (20th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580199/all/idecabtagene_vicleucel
Vallerand AHA, Sanoski CAC. Idecabtagene Vicleucel [Internet]. In: Davis's Drug Guide Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 October 12]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580199/all/idecabtagene_vicleucel.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - idecabtagene vicleucel
ID - 3580199
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580199/all/idecabtagene_vicleucel
PB - F.A. Davis Company
ET - 20
DB - Pediatrics Central
DP - Unbound Medicine
ER -
